Following the acquisition of its parent company FH Ortho by Olympus Corporation, Spine Innovations has become a fully independent entity dedicated to worldwide sales of its ESP® cervical and lumbar disc replacements.
ESP artificial discs use viscoelastic technology to mimic the characteristics of natural discs and provide similar motion behavior, restoring normal function and protecting adjacent spine levels.
Clinical evaluation that started in 2004 led to CE Mark approval for the LP-ESP® lumbar disc in 2006 and the CP-ESP® cervical disc in 2012. A dedicated spine unit was established in 2014, and now these products are available in more than 15 countries. Spine Innovations launched from FH Ortho in October 2020.
The LP-ESP and CP-ESP discs are considered to be third-generation products in the evolution of total disc replacements.
Sandrine Carle, President of Spine Innovations, said, "This is an important milestone for Spine Innovations, and I am so enthusiastic to contribute to its exceptional growth. This autonomy will allow us to strengthen our team for a strong penetration of the worldwide total disc market with our unique viscoelastic technology."